The federal government will again be distributing free COVID-19 tests to U.S. households. Here's when and how to order them in Texas.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Bronchiolitis alarm in children, there is a life-saving drug but not all Regions can purchase it. The seasonal epidemic of ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

Oregon public health officials urge people to stay up to date on their vaccinations as the winter respiratory illness season ...

Older adults now have access to two approved vaccines, called Arexvy and Abrysvo. Guidance from the National Advisory Committee on Immunization (NACI) recommends RSV vaccination for any adults aged 75 ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

UNICEF said 60% of the nearly 22,000 suspected and confirmed mpox cases in Africa this year are in children younger than 15 ...

On the first week of September (2-8), 81 suspected cases of whooping cough were registered by GPs in Hungary, according to ...

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...